![]() |
市场调查报告书
商品编码
1654306
美国眼部护理市场规模、份额、趋势分析报告:按产品、购买类型、分销管道、细分预测,2025-2030 年U.S. Eye Care Market Size, Share & Trends Analysis Report By Product (Contact Lens, Ocular Health Products), By Mode Of Purchase (Over The Counter, Prescribed), By Distribution Channel, By Country, And Segment Forecasts, 2025 - 2030 |
预计到 2024 年,美国眼保健市场价值将达到 273 亿美元,预计从 2025 年到 2030 年,复合年增长率将达到 7.1%,这主要得益于近视、青光眼和白内障等视力障碍盛行率的上升。
社会老化加剧,65岁以上成年人口超过5,400万,对眼部保健服务及产品的需求也随之增加。微创手术设备和先进的诊断工具等技术进步正在改善治疗效果。人们对预防性眼部护理意识的增强和数位设备的普及推动了对蓝光阻挡镜片等解决方案的需求。强大的医疗保健基础设施以及对眼科研究和创新的大力投资进一步支持了美国市场。
2023 年 9 月,博士伦推出了 Lumify Eye Illuminations 系列,其中包括胶束清洁水、睫毛和眉毛精华液以及 HydraGel 亮白霜等低过敏性产品。该系列产品与眼科医生和皮肤科医生合作开发,将安全放在首位,已有超过 15,000 次使用证明这一点。这些产品不含苯甲酸酯类、硫酸盐和酒精等刺激性化学物质,满足了日益增长的消费者对温和而有效的眼部护理解决方案的偏好。
美国眼保健市场的另一个显着发展是 Iridex 推出其下一代雷射 Iridex 532 和 Iridex 577。这些先进的平台是在该公司成立 35 週年之际推出的,采用了专利的微脉衝技术,并提供多种治疗模式来治疗视网膜疾病和青光眼。这些雷射具有直觉的触控萤幕介面,可增强临床控制并提高治疗精度。此公告是在 2024 年夏威夷眼科与视网膜会议召开之前发布的,凸显了 Iridex 对创新的承诺以及为全球眼科医生提供可靠雷射系统的传统。 Iridex 总裁兼执行长 Bruce 表示,这些雷射代表着将尖端技术与以用户为中心的设计相结合的关键进步,可以优化患者照护。
此外,微创手术设备和个人化护理等诊断工具和治疗方案的进步正在改变眼科护理模式。消费者对同时满足功能性和美观性的产品的需求也在塑造市场趋势。例如,Lumify Eye Illuminations 等低过敏性、营养丰富的产品满足了人们对有效且温和的解决方案日益增长的偏好。
The U.S. eye care market size was estimated at USD 27.3 billion in 2024 and is expected to grow at a CAGR of 7.1% from 2025 to 2030, driven by a rising prevalence of vision disorders such as myopia, glaucoma, and cataracts. An aging population, with over 54 million adults aged 65 and older, contributes to increased demand for eye care services and products. Technological advancements, including minimally invasive surgical devices and advanced diagnostic tools, are enhancing treatment outcomes. Growing awareness of preventive eye care and the increasing adoption of digital devices are fueling demand for solutions like blue-light-blocking lenses. The U.S. market is further supported by robust healthcare infrastructure and strong investments in ophthalmic research and innovation.
In September 2023, Bausch + Lomb launched its Lumify Eye Illuminations line, featuring hypoallergenic products such as micellar cleansing water, lash and brow serum, and hydra-gel brightening cream. Developed with ophthalmologists and dermatologists, the line prioritizes safety, as demonstrated in over 15,000 applications. Free from harsh chemicals such as parabens, sulfates, and alcohol, these products address growing consumer preferences for gentle, effective eye care solutions.
Another notable development in the U.S. eye care market is the introduction of Iridex Corp's next-generation Iridex 532 and Iridex 577 lasers. Launched in conjunction with the company's 35th anniversary, these advanced platforms incorporate patented MicroPulse Technology and offer multiple treatment modes to address retinal disorders and glaucoma. Featuring an intuitive touchscreen interface, these lasers enhance clinical control and improve treatment precision. The announcement was made ahead of the Hawaiian Eye and Retina 2024 meeting, underscoring Iridex's commitment to innovation and its legacy of providing reliable laser systems to ophthalmologists worldwide. According to David Bruce, President and CEO of Iridex, these lasers represent a pivotal step forward, combining cutting-edge technology with user-centric design to optimize patient care.
In addition, advancements in diagnostic tools and treatment options, such as minimally invasive surgical devices and personalized therapies, are transforming the landscape of eye care. Consumer demand for products that address both functional and cosmetic needs is also shaping market trends. For instance, hypoallergenic and nutrient-enriched products, such as Lumify Eye Illuminations, cater to the growing preference for solutions that are both effective and gentle.
U.S. Eye Care Market Report Segmentation
This report forecasts revenue growth at country levels and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. eye care market report based on product, mode of purchase, and distribution channel: